Clinical Trial Update: Albendazole Plus High Dose Ivermectin for Trichuriasis in Pediatric Patients [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating a combination of albendazole and high-dose ivermectin for trichuriasis in pediatric patients has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Helminthiasis
• Trichuris Infection

Drugs mentioned

• Albendazole (ALBENDAZOLE)
• Ivermectin (high-dose) (ivermectin)

Snippet

Sponsor: Alejandro Krolewiecki | Conditions: Trichuris Infection, Helminthiasis | Phase 2 | Status: COMPLETED | Results posted: 2020-07-29